THURSDAY, Feb. 10, 2022 (HealthDay News) The mononucleosis virus, Epstein-Barr, has become a major suspect in the search for what causes multiple sclerosis.
THURSDAY, Feb. 10, 2022 (HealthDay News) The mononucleosis virus, Epstein-Barr, has become a major suspect in the search for what causes multiple sclerosis.
Trial of Rhythmic Sound Therapy to Aid Walking in MS Launching multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.
MedRhythms and Massachusetts General Hospital Launch Study of Gait Asset for Multiple Sclerosis
MedRhythms announces the launch of a clinical trial, in collaboration with Massachusetts General Hospital (MGH), that will study MR-004, MedRhythms’ multiple sclerosis (MS) asset.
The trial was funded by the National Multiple Sclerosis Society, aims to study the impacts of Rhythmic Auditory Stimulation on MS walking impairments. It expands on the research that is being conducted with MR-004 in a clinical trial with Cleveland Clinic that was announced in 2020.
The trial will be led at MGH by Co-Principal Investigators, Dr. Eric Klawiter and Dr. Ron Hirschberg, and will be a randomized crossover trial looking at the impacts of MR-004, a digital therapeutic that digitizes Rhythmic Auditory Stimulation, on functional outcomes such as gait speed as well as neuroimaging compared to standard of care, a media release from MedRhythms explains.